SUPERNUS PHARMACEUTICALS INC (SUPN)

US8684591089 - Common Stock

29.1  -0.06 (-0.21%)

After market: 29.1 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
597.46M607.52M667.20M579.80M520.40M
Cost Of Goods
76.64M83.78M87.20M75.10M52.50M
Gross Profit
520.82M523.74M580.00M504.70M467.90M
Operating Expenses
514.18M508.82M533.90M396.30M285.80M
Research and Development
95.38M91.59M74.60M90.50M76.00M
Selling, General, and Administrative Expenses
337.30M336.36M377.20M282.50M192.30M
Operating Income
6.54M14.92M46.10M108.30M182.10M
Interest Income/Expense
7.88M8.60M17.00M-9.10M-700.00K
Other Income/Expense
N/A-562.00K-2.40M-3.70M-4.30M
Non Recurring Items
N/A-20.19MN/A-22.30M-8.40M
Income Before Taxes
-5.97M2.77M60.70M73.20M168.60M
Income Tax
9.53M1.45M0.0019.80M41.70M
Net Income
-15.50M1.32M60.70M53.40M127.00M
EBITDA
91.55M99.78M131.60M140.90M200.20M
 
Per Share Data
EPS Diluted Total Ops
-0.290.020.980.982.36
Non GAAP EPS
1.371.401.030.982.36
 
Statistics
Gross Profit Margin
87.17%86.21%86.93%87.05%89.91%
Profit Margin
-2.59%0.22%9.10%9.21%24.40%
Operating Profit Margin
1.09%2.46%6.91%18.68%34.99%

All data in USD

Charts